Luteonin-mediated Km-1 / NF-kB / Nrf2 Signaling Pathways Protects Sodium Fluoride Induced Hypertension and Cardiovascular Complications. Biofactors.

dc.contributor.authorOyagbemi, A. A.
dc.contributor.authorOmobowale, T. O.
dc.contributor.authorOla-Davies, O. E.
dc.contributor.authorAsenuga, E. R.
dc.contributor.authorAjibade, T. O.
dc.contributor.authorAdejumobi, O. A.
dc.contributor.authorAfolabi, J. M.
dc.contributor.authorOgunpolu, B. S.
dc.contributor.authorFalayi, O. O.
dc.contributor.authorSaba, A. B.
dc.contributor.authorAdedapo, A. A.
dc.contributor.authorYakubu, M. A.
dc.date.accessioned2026-05-25T13:15:41Z
dc.date.issued2018
dc.description.abstractThe use of sodium fluoride (NaF) as a major ingredient for toothpaste, mouth wash, and mouth rinse has become inevitable in our day-to-day life. However, flavonoids such as Luteolin might be of great value in the prevention of toxicity associated with accidental or inevitable ingestion of NaF. In the study, 40 male Wistar albino rats were randomly divided into four groups with 10 rats in a group. Group A was the control group and received normal saline, Group B was exposed to NaF at 300 ppm (300 mg/L) in drinking water daily for a week, Groups C and D were exposed to 300 ppm (300 mg/L) of NaF and co-administered with Luteolin orally daily at a dosage of 100 mg/kg and 200 mg/kg for the same time point. Our results indicated that NaF caused significant increases in systolic blood pressure, diastolic blood pressure, mean arterial pressure, malondialdehyde, protein carbonyl, myeloperoxidase, advanced oxidative protein products, together with significant reductions in glutathione peroxidase, superoxide dismutase, catalase, glutathione reductase, reduced glutathione, and nitric oxide (NO) bioavailability. The electrocardiogram results showed that NaF alone caused significant prolongation of QT and QTc intervals. Immunohistochemistry revealed that NaF caused increase expressions of Kidney injury marker 1 (Kim-1), nuclear factor kappa beta (NF-κB), nuclear factor erythroid 2-related factors 2 (Nrf2), and cardiac troponin I (CTnI). Together, Luteolin co-administration with NaF improved NO bioavailability, reduced high blood pressure, markers of oxidative stress, reversed prolongation of QT and QTc intervals, and lowered the expressions of Kim-1, NF-κB, and CTnI.
dc.identifier.issn872-8081
dc.identifier.otherui_art_oyagbemi_luteolin_2018
dc.identifier.otherBiofactors, 44(6), pp. 518–531
dc.identifier.urihttps://repository.ui.edu.ng/handle/123456789/14168
dc.language.isoen
dc.publisherWiley-Blackwell
dc.subjectsodium fluoride
dc.subjectLuteolin
dc.subjectHypertension
dc.subjectNutraceuticals
dc.titleLuteonin-mediated Km-1 / NF-kB / Nrf2 Signaling Pathways Protects Sodium Fluoride Induced Hypertension and Cardiovascular Complications. Biofactors.
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
(28) ui_art_oyagbemi_luteolin_2018.pdf
Size:
2.07 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.61 KB
Format:
Item-specific license agreed upon to submission
Description: